HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Significance of uterine corpus tumor invasion in early-stage cervical cancer.

AbstractOBJECTIVE:
To examine characteristics and survival outcomes of women with surgically-treated cervical cancer exhibiting uterine corpus tumor invasion.
METHODS:
We utilized The Surveillance, Epidemiology, and End Results Program to identify cervical cancer patients who underwent hysterectomy between 1973 and 2003. Logistic regression models were used to identify risk factors for uterine corpus tumor invasion on multivariable analysis. Association of uterine corpus tumor invasion and cause-specific survival (CSS) from cervical cancer was examined with Cox proportional hazard regression models on multivariable analysis.
RESULTS:
We identified 837 (4.9%) cases of uterine corpus invasion and 16,237 (95.1%) cases of non-invasion. Median follow-up time was 14.0 years. There were 1642 deaths due to cervical cancer. Uterine corpus invasion was independently associated with older age, non-squamous histology, high-grade tumors, large tumor size, and nodal metastasis on multivariable analysis (all, P < 0.001). On univariable analysis, uterine corpus tumor invasion was significantly associated with decreased CSS compared to the non-invasion (5-year rates, 79.0% versus 94.5%, P < 0.001). After controlling for other significant prognostic factors, uterine corpus tumor invasion remained an independent prognostic factor for decreased CSS (adjusted-hazard ratio 1.45, 95% confidence interval 1.21-1.74). Among stage T1b cases (n = 6730), uterine corpus tumor invasion remained an independent prognostic factor for decreased CSS (adjusted-hazard ratio 1.95, 95%CI 1.47-2.60). Uterine corpus tumor invasion was significantly associated with decreased CSS in stage T1b1 disease (74.5% versus 90.7%, P < 0.001) and in stage T1b2 disease (67.0% versus 79.5%, P = 0.01).
CONCLUSION:
Uterine corpus tumor invasion is an independent prognostic factor for decreased survival of women with early-stage cervical cancer.
AuthorsK Matsuo, H Machida, E A Blake, T Takiuchi, M Mikami, L D Roman
JournalEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology (Eur J Surg Oncol) Vol. 43 Issue 4 Pg. 725-734 (Apr 2017) ISSN: 1532-2157 [Electronic] England
PMID28215507 (Publication Type: Journal Article)
CopyrightCopyright © 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
Topics
  • Adenocarcinoma (mortality, pathology, therapy)
  • Adult
  • Black or African American (statistics & numerical data)
  • Brachytherapy
  • Carcinoma, Adenosquamous (mortality, pathology, therapy)
  • Carcinoma, Squamous Cell (mortality, pathology, therapy)
  • Female
  • Hispanic or Latino (statistics & numerical data)
  • Humans
  • Hysterectomy
  • Kaplan-Meier Estimate
  • Logistic Models
  • Lymph Nodes (pathology)
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Prognosis
  • Proportional Hazards Models
  • Radiotherapy, Adjuvant
  • SEER Program
  • Survival Rate
  • United States
  • Uterine Cervical Neoplasms (mortality, pathology, therapy)
  • Uterus (pathology)
  • White People (statistics & numerical data)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: